Sol J. Barer, Director at Aevi Genomic Medicine, Inc. (GNMX), sold 8,563,358 shares at $0.13 ($1.1M) on 2019-12-05, disclosed to the SEC on 2019-12-09.
Open-market sale of $1.1M GNMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 365,854 | $0 | 0.0% |
| 2 | $0.13 | 4,098,752 | $533K | 50.0% |
| 3 | $0.13 | 4,098,752 | $533K | 50.0% |
| Total | $0.12 avg | 8,563,358 | $1.1M | 100% |
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |